Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients

Clinical trial NCT00708916 · COMPLETED

Trial details

NCT number: NCT00708916
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Discoid Lupus Erythematosus

Start date: 2008-06-01
Primary completion: 2010-08-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.